Recursion Pharmaceuticals... (RXRX)

AI Score

Unlock

5.50

0.18 (3.38%)

At close: Apr 17, 2025, 3:59 PM

Recursion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	594.35M	427.65M	476.12M	299.52M	394.8M	387.32M	405.87M	473.14M	549.91M	454.65M	453.88M	507.89M	285.12M	394.72M	632.74M	214.09M	262.13M	-69.88M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	61.56M	83.21M	231.45M	184.19M	n/a	n/a	n/a	139.77M
Long-Term Investments	n/a	n/a	6.63M	6.63M	6.63M	7.63M	7.63M	7.92M	7.92M	8.15M	8.33M	8.71M	8.68M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	14.45M	6.99M	308K	254K	-36.18M	7.78M	7.74M	8M	7.92M	8.15M	8.33M	36K	35K	35K	68K	3.06M	650K	-69.88M
Receivables	49.17M	2.25M	2.53M	2.6M	3.09M	3.16M	3.05M	2.06M	2.75M	11.63M	11.68M	11.4M	9.09M	2.28M	49K	71K	156K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	2.26M	3.33M	1.31M	1.28M	2.09M	1.9M	1.52M	1.55M	10.23M	10.23M	5.04M	5.04M	n/a
Other Current Assets	70.75M	44.27M	45.51M	41.49M	43.48M	20.04M	22.1M	16.92M	17.15M	15.34M	18.88M	16.95M	9.07M	19.68M	14.85M	7.66M	4.16M	n/a
Total Current Assets	714.27M	474.17M	522.38M	343.62M	438.14M	410.52M	431.02M	492.13M	569.81M	481.62M	546M	619.46M	534.72M	600.87M	647.63M	221.82M	269.48M	69.88M
Property-Plant & Equipment	233.21M	159.19M	156.28M	122.22M	120.17M	120.31M	124.67M	125.12M	121.45M	119.5M	116.15M	104M	64.72M	55.44M	48.55M	44.64M	25.97M	n/a
Goodwill & Intangibles	484.73M	86.15M	90.27M	85.13M	88.5M	92.21M	103.27M	2.12M	2.11M	2.26M	2.03M	2.11M	2.19M	2.26M	2.34M	2.41M	2.49M	n/a
Total Long-Term Assets	734.33M	252.33M	253.49M	214.23M	215.56M	220.3M	235.68M	135.24M	131.47M	129.91M	126.52M	114.86M	75.63M	57.74M	50.95M	50.12M	29.11M	-69.88M
Total Assets	1.45B	726.5M	775.86M	557.85M	653.7M	630.83M	666.7M	627.37M	701.29M	611.53M	672.51M	734.32M	610.35M	658.61M	698.59M	271.94M	298.58M	n/a
Account Payables	21.61M	2.26M	3.76M	5.12M	3.95M	4.26M	2.09M	4.25M	4.59M	3.89M	3.18M	4.16M	2.82M	6.33M	3.2M	3.13M	1.07M	n/a
Deferred Revenue	61.77M	49.58M	32.2M	36.62M	36.43M	44M	73.11M	57.76M	56.73M	46.75M	63.78M	54.25M	10M	10M	10M	10M	10M	n/a
Short-Term Debt	8.43M	8.22M	16.72M	55K	6.16M	6.05M	5.89M	5.1M	97K	5.64M	5.33M	4.18M	1.51M	1.5M	3.63M	2.64M	1.07M	n/a
Other Current Liabilities	50.85M	19.66M	11.68M	16.02M	17.63M	16.88M	11.8M	10.36M	12.47M	9.4M	11.12M	13.11M	20.59M	7.26M	4.4M	1.8M	10M	n/a
Total Current Liabilities	187.47M	108.89M	86.08M	73.92M	93.17M	94.12M	113.96M	92.15M	100.27M	83.04M	96.65M	85.7M	46.66M	42.94M	29.54M	26.85M	23.1M	n/a
Long-Term Debt	19.02M	20.51M	22.92M	1.07M	1.1M	1.13M	1.16M	1.18M	536K	561K	586K	610K	633K	656K	9.42M	10.34M	11.41M	n/a
Other Long-Term Liabilities	4.73M	18.71M	3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.11M	3.35M	2.82M	2.75M	450.99M	n/a
Total Long-Term Liabilities	226.34M	93.05M	105.33M	82.78M	97.09M	98.74M	83.78M	105.04M	115.22M	140.46M	138.28M	155.05M	20.75M	16.63M	26.34M	478.12M	481.77M	n/a
Total Liabilities	413.82M	201.94M	191.41M	156.7M	190.26M	192.86M	197.74M	197.19M	215.48M	223.5M	234.94M	240.75M	67.41M	59.57M	55.88M	504.97M	504.87M	n/a
Total Debt	108.49M	90.63M	89.88M	50.97M	50.67M	51.48M	52.9M	53.05M	51.01M	52.19M	53.68M	52.1M	11.48M	5.62M	15.48M	15.54M	15.66M	n/a
Common Stock	4K	3K	3K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	n/a	n/a	n/a
Retained Earnings	-1.43B	-1.25B	-1.16B	-1.06B	-967.62M	-874.63M	-781.61M	-704.88M	-639.56M	-582.06M	-521.62M	-456.06M	-400.08M	-335.15M	-287.72M	-244.32M	-213.6M	n/a
Comprehensive Income	-7.64M	n/a	n/a	n/a	-0.00	n/a	0.00	n/a	0.00	-0.00	-197K	-309K	-126K	2K	-698.59M	n/a	n/a	-124.27M
Shareholders Equity	1.03B	524.56M	584.45M	401.15M	463.44M	437.97M	468.96M	430.18M	485.81M	388.03M	437.58M	493.57M	542.94M	599.03M	642.71M	-233.03M	-206.29M	76.84M
Total Investments	n/a	n/a	6.63M	6.63M	6.63M	7.63M	7.63M	7.92M	7.92M	8.15M	61.56M	83.21M	231.45M	184.19M	n/a	n/a	n/a	139.77M